Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Hunger hormone could signal treatments for Parkinson’s

As Americans anticipate their Thanksgiving dinners, the gnawing sensation of hunger prepares them to eat perhaps too much turkey or pumpkin pie. The same hormone that produces that sensation of hunger could be the secret to a new therapy protecting Parkinson’s patients from disease-related cell death, according to research presented Nov. 16 during the Society of Neuroscience’s annual meeting in Chicago.

Thumbnail

Breast cancer model could usher in new generation of imaging, therapy

A trifecta of cells has been revealed to be the crux of breast cancer metastases. The discovery provides cutting-edge details that could revolutionize the development of diagnostic testing and therapeutic agents for breast cancer, officials at the Albert Einstein College of Medicine in New York announced yesterday.

Thumbnail

RSNA: Avoiding pitfalls in breast radiology

CHICAGO—Despite concerns from radiologists about reading breast imaging exams due to medicolegal notoriety, most breast imaging exams in the country are still being read by radiologists who lack dedicated breast imaging training.

Thumbnail

Autopsy shows Williams had DLB

The recent death of the beloved comedian and actor Robin Williams by suicide took fans by complete surprise and left many in mourning for the master of improvisation. A recent report in Salon provides details from Williams' autopsy report that indicates the presence of dementia with Lewy bodies (DLB), which may explain some of his uncharacteristic behavior of late. In addition to DLB, Williams also suffered from Parkinson's.

Thumbnail

Novel imaging agent targets pancreatic cancer

MabVax Therapeutic Holdings, in collaboration with the Memorial Sloan Kettering Cancer Center (MSKCC), is presenting an investigational agent for imaging pancreatic cancer and aiding pancreatic tumor resection, MabVax announced Nov. 19.

Thumbnail

The age of theranostic nanoparticles

Over the past several years, theranostic nanoparticle studies have provided several shining examples of where molecular cancer imaging is going. In this review published ahead of print Nov. 20 in the Journal of Nuclear Medicine, researchers discuss the triumphs and tribulations of these tiny yet potent structures.

Thumbnail

Year in Images 2014

This year, Molecular Imaging Insight is not only providing some of the most stunning images from our pages, but also a few research exclusives and offerings from a handful of scientific meetings from around the world, including the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the World Molecular Imaging Congress (WMIC) and the European Congress of Radiology (ECR).

Thumbnail

The Evolution of SPECT

The evolution of SPECT imaging has taken many twists and turns as both equipment technology and new radiopharmaceuticals have been developed over the past decade.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.